Bruce G. Redman
Department of Internal Medicine
Division of Hematology/Oncology
University of Michigan
1500 E. Medical Center Drive
USA
Name/email consistency: high
- Phase Ib trial assessing autologous, tumor-pulsed dendritic cells as a vaccine administered with or without IL-2 in patients with metastatic melanoma. Redman, B.G., Chang, A.E., Whitfield, J., Esper, P., Jiang, G., Braun, T., Roessler, B., Mulé, J.J. J. Immunother. (2008)
- Phase II trial of tetrathiomolybdate in patients with advanced kidney cancer. Redman, B.G., Esper, P., Pan, Q., Dunn, R.L., Hussain, H.K., Chenevert, T., Brewer, G.J., Merajver, S.D. Clin. Cancer Res. (2003)
- Phase II trial of paclitaxel and carboplatin in the treatment of advanced urothelial carcinoma. Redman, B.G., Smith, D.C., Flaherty, L., Du, W., Hussain, M. J. Clin. Oncol. (1998)